Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites
Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews he...
Saved in:
Main Author: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2018
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_49994 | ||
005 | 20210211 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210211s2018 xx |||||o ||| 0|eng d | ||
020 | |a 978-2-88945-535-5 | ||
020 | |a 9782889455355 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3389/978-2-88945-535-5 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
100 | 1 | |a Lois A. Lampson |4 auth | |
245 | 1 | 0 | |a Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
260 | |b Frontiers Media SA |c 2018 | ||
300 | |a 1 electronic resource (95 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Frontiers Research Topics | |
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews herein emphasize the brain's place among other tumor sites. Two major topics are addressed. THE SITE: WHAT CAN WE EXPECT FROM IMMUNOTHERAPY WHEN THE TARGET IS IN THE BRAIN? Experience with immunotherapy for different targets in the brain, including tumor and also pathogens, is reviewed. Long-standing assumptions are confronted. The potential for beneficial responses is stressed. BRAIN TUMOR IMMUNOTHERAPY: WHAT HAVE WE LEARNED SO FAR? Clinical experience with brain tumor immunotherapy, from a variety of centers, is reviewed. Primary tumors, emphasizing glioblastoma, and brain metastases are each considered. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine |2 bicssc | |
653 | |a blood-brain barrier | ||
653 | |a tumor antigen | ||
653 | |a brain immunology | ||
653 | |a glioblastoma | ||
653 | |a brain tumor immunotherapy | ||
653 | |a brain metastases | ||
653 | |a brain tumor | ||
653 | |a immune privilege | ||
856 | 4 | 0 | |a www.oapen.org |u https://www.frontiersin.org/research-topics/2186/immunotherapy-for-tumor-in-the-brain-insights-from---and-for---other-tumor-sites |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/49994 |7 0 |z DOAB: description of the publication |